OLMA
NASDAQ
US
Olema Pharmaceuticals, Inc. - Common Stock
$15.06
▼ $-0.06
(-0.40%)
Vol 904K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.0B
ROE
-41.5%
D/E
0.98
Beta
1.87
52W
$3–$36
Wall Street Consensus
19 analysts · Apr 20267
Strong Buy
10
Buy
2
Hold
0
Sell
0
Strong Sell
89.5%
Buy Rating
Price Chart
Similar Stocks
IOVA
Iovance Biotherapeutics Inc
$1.1B
PGEN
Precigen Inc
$1.5B
GLUE
Monte Rosa Therapeutics Inc
P/E 48.7
$1.0B
BCAX
Bicara Therapeutics Inc
$922.0M
ZBIO
Zenas Biopharma Inc
$2.3B
TSHA
Taysha Gene Therapies Inc
$1.5B
NVAX
Novavax Inc
P/E 3.2
$1.1B
CRVS
Corvus Pharmaceuticals Inc
$575.1M
SVRA
Savara Inc
$1.2B
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.54
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.54 | — | — |
| Dec 2025 | $-0.54 | $-0.50 | +$0.04 |
| Sep 2025 | $-0.49 | $-0.49 | +$0.00 |
| Jun 2025 | $-0.38 | $-0.51 | $-0.13 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -42.6% | -42.6% | -42.6% | -42.6% | -42.6% | -41.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.98 |
| Current Ratio | 11.09 | 11.09 | 11.09 | 11.09 | 11.09 | 8.03 |
Key Ratios
ROA (TTM)
-37.6%
P/B
0.8
EPS (TTM)
$-1.81
CF/Share
$-2.30
52W High
$36.26
52W Low
$2.86
$2.86
52-Week Range
$36.26
How does OLMA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
OLMA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.8
▼
67%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
OLMA profitability vs Biotechnology peers
ROE
-41.5%
▲
38%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-37.6%
▲
19%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
OLMA financial health vs Biotechnology peers
D/E ratio
1.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
8.0
▲
81%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.9
▲
93%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
OLMA fundamentals radar
OLMA
Peer median
Industry
OLMA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio